1 results match your criteria: "The University of Texas MD Anderson Medical Center[Affiliation]"
Osimertinib, Surgery, and Radiation Therapy in Treating Patients with Stage IIIB or IV Non-Small Cell Lung Cancer with EGFR Mutations (NORTHSTAR).
Ann Surg Oncol
August 2022
Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Medical Center, Houston, TX, USA.